Abstract
Gram-negative endocarditis due to HACEK bacteria (Haemophilus species, Actinobacillus, Cardiobacterium, Eikenella and Kingella species) and non-HACEK organisms is an infrequent occurrence but is associated with significant morbidity and mortality. Traditionally, non-HACEK Gram-negative endocarditis has been associated with injection drug use. However, emerging data from more contemporary cohorts suggest changing epidemiology and risk factors for Gram-negative endocarditis, necessitating an updated review of this subject. Moreover, optimal management, including the need for surgical intervention, and strategies for the prevention of Gram-negative endocarditis need to be revisited.
Original language | English (US) |
---|---|
Pages (from-to) | 879-885 |
Number of pages | 7 |
Journal | Expert Review of Anti-Infective Therapy |
Volume | 8 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2010 |
Keywords
- Gram-negative
- HACEK
- bacilli
- endocarditis
- management
- recommendations
ASJC Scopus subject areas
- Microbiology
- Microbiology (medical)
- Virology
- Infectious Diseases